Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 13 Proposed management of bladder cancer with variant histology

Published byRosemary Hancock Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 13 Proposed management of bladder cancer with variant histology"— Presentation transcript:

1 Figure 13 Proposed management of bladder cancer with variant histology
Figure 13 | Proposed management of bladder cancer with variant histology. Proposed management algorithm for non-muscle invasive bladder cancer (NMIBC, black arrows) and muscle invasive bladder cancer (MIBC, red arrows) with variant histology. Dashed arrows indicate a low level of evidence. Adapted from Willis, D. L., Porten, S. P. & Kamat, A. M. Should histologic variants alter definitive treatment of bladder cancer? Curr. Opin. Urol. 23, 435–443 (2013)147. LVI, lymphovascular invasion. *Nonurachal ‡Pure neuroendocrine. Adapted from Willis, D. L., Porten, S. P. & Kamat, A. M. Should histologic variants alter definitive treatment of bladder cancer? Curr. Opin. Urol. 23, 435–443 (2013)147. Moschini, M. et al. (2017) Characteristics and clinical significance of histological variants of bladder cancer Nat. Rev. Urol. doi: /nrurol

Download ppt "Figure 13 Proposed management of bladder cancer with variant histology"

Similar presentations

Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.

Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 4 Types of urinary diversion

Figure 4 Types of urinary diversion
Figure 1 Male infertility and assisted reproduction globally

Figure 1 Male infertility and assisted reproduction globally
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 2 Recruitment of experts to the Delphi study

Figure 2 Recruitment of experts to the Delphi study
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 5 Types of urinary diversion

Figure 5 Types of urinary diversion
Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.

Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.
Figure 1 Cellular processes involved in cancer development

Figure 1 Cellular processes involved in cancer development
Figure 3 Birt–Hogg–Dubé (BHD) renal tumour histology

Figure 3 Birt–Hogg–Dubé (BHD) renal tumour histology
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 3 Semantic model of the active surveillance (AS) timeline

Figure 3 Semantic model of the active surveillance (AS) timeline
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Volume 199, Issue 5, Pages (May 2018)

Volume 199, Issue 5, Pages (May 2018)
Figure 1 Postulated mechanisms of action of PD‑1, PD‑L1 and PD‑L2

Figure 1 Postulated mechanisms of action of PD‑1, PD‑L1 and PD‑L2
Nat. Rev. Clin. Oncol. doi: /nrclinonc

Nat. Rev. Clin. Oncol. doi: /nrclinonc
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Similar presentations

Ads by Google